Inactive Instrument
Eurofins-Cerep Stock Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 77.17M 88.51M 71.47M 66.91M 125M 8.35B 126M 848M 329M 4.11B 332M 325M 14.27B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 56.14M 64.39M 51.99M 48.67M 91.28M 6.08B 91.83M 617M 239M 2.99B 242M 237M 10.38B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +4,900.50% | - | - | 88.51M | |
| +1.44% | +1.71% | -10.63% | -9.16% | 43.13B | |
| +3.31% | +5.93% | +308.19% | +562.02% | 34.65B | |
| +2.84% | +2.14% | +6.87% | +34.93% | 30.03B | |
| -1.70% | -7.54% | +8.51% | -22.34% | 28B | |
| -1.90% | -1.56% | +11.62% | +19.80% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +52.04% | +107.47% | 13.14B | |
| -0.57% | -2.43% | +5.18% | +4.20% | 12.53B | |
| -0.26% | +1.15% | +100.27% | +80.69% | 12.25B | |
| Average | +0.37% | +0.73% | +60.26% | +97.20% | 23.61B | |
| Weighted average by Cap. | +0.77% | +1.27% | +65.22% | +113.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.44M 37.5M 35.1M 65.83M 4.38B 66.23M 445M 172M 2.16B 174M 171M 7.49B | 41.1M 47.14M 38.06M 35.63M 66.83M 4.45B 67.23M 452M 175M 2.19B 177M 173M 7.6B |
| Net income | 7.15M 8.21M 6.63M 6.2M 11.63M 774M 11.7M 78.61M 30.47M 381M 30.8M 30.14M 1.32B | 4.78M 5.49M 4.43M 4.15M 7.78M 518M 7.82M 52.55M 20.36M 255M 20.59M 20.15M 885M |
| Net Debt | -17.25M -19.79M -15.98M -14.96M -28.05M -1.87B -28.22M -190M -73.47M -919M -74.28M -72.68M -3.19B | -21.03M -24.13M -19.48M -18.24M -34.2M -2.28B -34.41M -231M -89.57M -1.12B -90.56M -88.62M -3.89B |
Employees
-
